South Korea's Samsung Biologics rallies after avoiding delisting

South Korea's Samsung Biologics rallies after avoiding delisting

Samsung BioLogics Co. signage is seen behind medicine bottles on display at the company's headquarters and production facilities in Songdo district in Incheon, South Korea, on Wednesday, April 19, 2017. Photographer: SeongJoon Cho/Bloomberg

Samsung Group’s biotechnology arm rallied Tuesday as a Korea Exchange evaluation committee decided not to delist the unit’s shares after financial regulators concluded it violated accounting rules.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter